Galderma, the Swiss skincare specialist, has begun talks with international investors for a possible $22bn initial public offering in the first half of next year.
Chief executive Flemming Ornskov, the former boss of rare diseases specialist Shire, told the Financial Times that Galderma and its owners had accelerated strategic planning after two years of bumper growth thanks in part to the Covid-19 pandemic.
Galderma was spun out of Nestlé in 2019 and bought by a consortium for $10bn led by private equity house EQT and including Singapore’s GIC and the Abu Dhabi Investment Authority.
您已閱讀15%（589字），剩餘85%（3428字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。